KIDS ORTHOPEDIATRICS CORP

Nasdaq orthopediatrics.com


$ 16.43 $ -0.43 (-2.55 %)    

Monday, 03-Nov-2025 15:59:54 EST
QQQ $ 623.90 $ 0.00 (0 %)
DIA $ 470.32 $ 0.00 (0 %)
SPY $ 676.58 $ 0.00 (0 %)
TLT $ 89.88 $ 0.00 (0 %)
GLD $ 367.29 $ 0.00 (0 %)
$ 16.41
$ 16.73
$ 16.01 x 30
$ 18.39 x 20
-- - --
$ 15.28 - $ 32.00
134,146
na
411.52M
$ 1.05
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-29-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 03-05-2025 01-01-1970 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 03-08-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-01-2023 06-30-2023 10-Q
11 05-02-2023 03-31-2023 10-Q
12 03-01-2023 12-31-2022 10-K
13 11-01-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 03-03-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 03-11-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-06-2020 03-31-2020 10-Q
24 03-05-2020 12-31-2019 10-K
25 11-08-2019 09-30-2019 10-Q
26 08-13-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 03-07-2019 12-31-2018 10-K
29 10-31-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-15-2018 03-31-2018 10-Q
32 03-15-2018 12-31-2017 10-K
33 11-13-2017 09-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-maintains-buy-on-orthopediatrics-lowers-price-target-to-26

Needham analyst Mike Matson maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $42 to $26.

 btig-reiterates-buy-on-orthopediatrics-maintains-23-price-target

BTIG analyst Ryan Zimmerman reiterates OrthoPediatrics (NASDAQ:KIDS) with a Buy and maintains $23 price target.

 orthopediatrics-affirms-fy2025-sales-guidance-of-233500m-234500m-vs-235476m-est

OrthoPediatrics (NASDAQ:KIDS) affirms FY2025 sales outlook from $233.500 million-$234.500 million to $233.500 million-$234.500 ...

 orthopediatrics-q3-adj-eps-024-beats-026-estimate-sales-61250m-miss-62410m-estimate

OrthoPediatrics (NASDAQ:KIDS) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.2...

 orthopediatrics-gets-fdas-approval-for-3p-pediatric-plating-platform-small-mini-system

OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (Nasdaq: KIDS), a company focused exclusively on adv...

 lake-street-maintains-buy-on-orthopediatrics-lowers-price-target-to-34

Lake Street analyst Ben Haynor maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $37 to $34.

 stifel-maintains-buy-on-orthopediatrics-lowers-price-target-to-20

Stifel analyst Rick Wise maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $32 to $20.

 jmp-securities-maintains-market-outperform-on-orthopediatrics-lowers-price-target-to-25

JMP Securities analyst David Turkaly maintains OrthoPediatrics (NASDAQ:KIDS) with a Market Outperform and lowers the price t...

 piper-sandler-maintains-overweight-on-orthopediatrics-lowers-price-target-to-22

Piper Sandler analyst Matt O'Brien maintains OrthoPediatrics (NASDAQ:KIDS) with a Overweight and lowers the price target...

 btig-maintains-buy-on-orthopediatrics-lowers-price-target-to-23

BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $39 to $23.

 orthopediatrics-lowers-fy2025-sales-guidance-from-237000m-242000m-to-233500m-234500m-vs-239440m-est

OrthoPediatrics (NASDAQ:KIDS) lowers FY2025 sales outlook from $237.000 million-$242.000 million to $233.500 million-$234.500 m...

 orthopediatrics-sees-q3-sales-61200m-vs-63590m-est

OrthoPediatrics (NASDAQ:KIDS) sees Q3 sales of $61.200 million vs $63.590 million analyst estimate.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION